Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C
Clinical trial NCT05395416 · COMPLETED
Trial details
- NCT number
- NCT05395416
- Sponsor
- Sunshine Lake Pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-21
- Primary completion
- 2023-04-11
- Enrollment
- 514
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.